u/nz_unfunded

completely different jurisdiction, similar carrier pattern. edit: which is either a coincidence or the brokerage explanation generalising, and two anecdotes cannot tell you which.

say which state only if it matters, but always say which country

Have you checked the shortage database directly?

Pharmacy staff name removed; the pharmacy itself can stay in a pricing post.

The 21% figure is a 72-week mean on the highest arm. Quoting it as what someone should expect by week 2 is not a fair reading.

Country added to the title. Australia and New Zealand answers differ and the thread was unusable without it.

Left up. It links the primary database rather than coverage of it, which is what we ask for.

Australia and New Zealand have different regulators, different funding bodies and different arrangements. An answer for one is not evidence about the other.

Where a supplier holds regional stock, ask which lines are actually held there rather than drop-shipped. It changes the lead time and it changes the customs question.

hold the dose that works, the ladder is not a leaderboard

Vials and pens carry the same molecule; what differs is fill volume, device tolerance and whether you are doing your own arithmetic. Neither is inherently more accurate.

Why this compound is not simply another agonist, which is how it gets described everywhere else.

Amylin is co-secreted with insulin and signals satiety through its own receptor complexes. It is a different axis from the incretin system, not a parallel version of it. That is why the combination story is interesting: two mechanisms that address appetite differently, rather than more agonism at one receptor.

It is also why the dosing intuitions people bring from the semaglutide and tirzepatide boards do not transfer. Different receptors, different exposure-response, and no published schedule anybody here can reason from.

hold the dose that works, the ladder is not a leaderboard

What is the waist doing? That is usually the number still moving during a scale stall.

Pharmacy staff name removed; the pharmacy itself can stay in a pricing post.

switching from sema is not a dose conversion, there is no clean equivalence

Agreed, with one qualifier: that is the mean of the top arm and the spread around it was enormous.

Is this about registration or about subsidy?

Left up. It links the primary database rather than coverage of it, which is what we ask for.

Cosigning on asking the pharmacy to check the wholesaler. It converts speculation into a fact in one phone call.

Yes, and the reason the wider-market table has no scores is that a score built on two reports would be a lie with a decimal point.

Did you ask for the batch-specific certificate, or the generic one?

Rang three pharmacies for a private price and got three different numbers, all in the same city.

The 21% figure is a 72-week mean on the highest arm. Quoting it as what someone should expect by week 30 is not a fair reading.

Country added to the title. Australia and New Zealand answers differ and the thread was unusable without it.

Same experience with the appetite effect being flatter across the week rather than front-loaded.

nothing containing this is approved as a standalone product

Someone posted US advice in an Australian thread and it took four replies to untangle it. Say your country.

the shortage listing has an expected resolution date on it

Left up. It links the primary database rather than coverage of it, which is what we ask for.

Country added to the title. Australia and New Zealand answers differ and the thread was unusable without it.

Hangzhou Meite Bio came up in three threads the week I was ordering and I could not find a single independent result for them anywhere. Went with a documented supplier instead.

three independent results beat thirty forum posts

the four-week step schedule is the label, not folklore

Not sure about this bit. The GIP arm being real does not tell you that it is what caused your particular week.

Country added to the title. Australia and New Zealand answers differ and the thread was unusable without it.

Behemoth Labz came up in three threads the week I was ordering and I could not find a single independent result for them anywhere. Went with a documented supplier instead.

Asked SSA for the batch record on a Tuesday and had the full document, batch and method line, before the end of the day.

Agreed — and the corollary is that "no data" and "bad data" have to be written differently. The table separates them for exactly that reason.

Left up. It links the primary database rather than coverage of it, which is what we ask for.

PBS-subsidised or private script?